Discontinuation report PREVYMIS
| Report ID | 261800 |
| Drug Identification Number | 02469405 |
| Brand name | PREVYMIS |
| Common or Proper name | Letermovir for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LETERMOVIR |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 480mg vial |
| ATC code | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-12-05 |
| Actual discontinuation date | |
| Remaining supply date | 2025-12-05 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | PREVYMIS® injection supplied in single-dose vials at a concentration of 20mg/mL remains available in the 240 mg (12 mL per vial) presentation (DIN 02469367). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-07-04 | French | Compare |
| v7 | 2025-07-04 | English | Compare |
| v6 | 2025-07-04 | French | Compare |
| v5 | 2025-07-04 | English | Compare |
| v4 | 2025-07-03 | French | Compare |
| v3 | 2025-07-03 | French | Compare |
| v2 | 2025-07-03 | English | Compare |
| v1 | 2025-07-03 | English | Compare |
Showing 1 to 8 of 8